Genexine

GE
GE

Genexine

South Korean biopharmaceutical company developing novel biologics for cancer and rare diseases.

1999ActiveSeoul, South Korea
Rate

About

Genexine is a biopharmaceutical company dedicated to developing innovative biologics to address serious health issues and improve patient lives. They focus on creating novel immunotherapies for cancer and antibody therapies for rare diseases, utilizing proprietary platforms like the long-acting hyFc® Fusion Platform and DNA Vaccine Platform. Their pipeline includes treatments for anemia, growth hormone deficiency, and cervical cancer, aiming to save lives through scientific innovation.

Signals agent

Reach companies that have budget right now

Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.

  • Just raised a roundFresh budget, the week it lands
  • Hiring sales and marketingGo-to-market roles mean money to spend
  • Hiring fastA jump in open roles across the company
  • In the newsLaunches and announcements worth a message
  • The decision makerWho to contact, with a message you can edit

Is your startup an alternative to Genexine?

People comparing tools land here. Get listed beside these.

Copy Genexine's SEO strategy

How often they publish, which searches their posts chase and their newest posts. Then outrank them.

All funding rounds

Key facts

Website
genexine.com
Headquarters
Seoul, South Korea
Founded
1999
Founder
Young-Chul Sung
Total funding
$296.5M (Funding)
Business model
B2B

Funding rounds

Funding rounds raised by Genexine
DateRoundAmountLead investors
21 Dec 2020Funding$63.5M
21 Mar 2018Post IPO$233M

Tech stack

Detected on genexine.com, last scanned 21 Nov 2026.

Email provider
Self-hosted

Benchmarking

See how your site ranks against 16,849 startups

Genexine sits in the 43rd percentile for Domain Rating. Check where yours lands, free.

Genexine has a Domain Rating of 35, the 43rd percentile of 16,849 startups we track.

Scores

Measured, not editorial

35

Measured by AhrefsAhrefs DR

Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.

Below median

Check yours
28

Measured by StartupHub.aiAgent Readiness

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Bottom 25%

Scan yours

Measured by StartupHub.aiSecurity

What this company’s API or MCP server gives an anonymous stranger: transport, whether anything answers without credentials, CORS, response headers and, when an MCP server replies, which of its tools can be called with no key. Scanned live, on request, because a security verdict months old is worse than none.

Click to scan

Agent Readiness

Can AI agents use your site?

Genexine scores 28. Check yours free in a few seconds, or let Max Agent rerun it daily.

Run it daily with Max Agent
Median 41Across 23,755 scanned sites

Get notified when Genexine changes

Used Genexine? Write a review and get $5 in credits

Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:

  • Email finder
  • Market Map Maker
  • Agent Readiness scans
  • Deep intel
  • Tech stack scans

Frequently asked

Who owns Genexine?

Genexine is privately held, owned by its founders and investors. Investors on record include IMM Investment and Mirae Asset. Exact stakes are not public.

Are there companies like Genexine?

Yes. We list 6 companies like Genexine, including Travere Therapeutics, BioNTech and Enterome. Genexine has raised more than 3 of the 5 with funding on record.

How much funding has Genexine raised?

Genexine has raised a total of $296.5M in funding. The most recent round on record is Funding.

SEC filings, insider activity, nonprofit links and pay benchmarks for Genexine:

Company details: from public sources. Funding: 2 rounds on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules

Categories

Need more than this profile? Deep intel researches any company website: team, funding, customers and tech.

Max Agent

Let Max Agent watch Genexine and its market for you

New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.

Free week

Starter listings, once

AI answers checked

Daily for 7 days

  • ChatGPT
  • Perplexity

Max Agent

$79 a month, or $9.99 with our badge on your site

AI answers checked

Every week

  • ChatGPT
  • Claude
  • Perplexity
  • Gemini